Defining the probability that a cell therapy will produce a malignancy.
作者信息
Prockop Darwin J
出版信息
Mol Ther. 2010 Jul;18(7):1249-50. doi: 10.1038/mt.2010.99.
Abstract
摘要
相似文献
1
Defining the probability that a cell therapy will produce a malignancy.
Mol Ther. 2010 Jul;18(7):1249-50. doi: 10.1038/mt.2010.99.
2
Characterization of EGFP-labeled mesenchymal stem cells and redistribution of allogeneic cells after subcutaneous implantation.
Arch Orthop Trauma Surg. 2008 Jul;128(7):751-9. doi: 10.1007/s00402-008-0585-y. Epub 2008 Feb 12.
3
Mesenchymal Stem Cell Functionalization for Enhanced Therapeutic Applications.
Tissue Eng Part B Rev. 2019 Feb;25(1):55-77. doi: 10.1089/ten.TEB.2018.0118. Epub 2018 Oct 27.
4
Concise Review: Mesenchymal Stem Cells: From Roots to Boost.
Stem Cells. 2019 Jul;37(7):855-864. doi: 10.1002/stem.3016. Epub 2019 Apr 30.
5
Cardiac Cell Therapy: Insights into the Mechanisms of Tissue Repair.
Int J Mol Sci. 2021 Jan 26;22(3):1201. doi: 10.3390/ijms22031201.
6
Adipose-Derived Mesenchymal Stem Cells: A New Tool for the Treatment of Renal Fibrosis.
Stem Cells Dev. 2018 Oct 15;27(20):1406-1411. doi: 10.1089/scd.2017.0304. Epub 2018 Aug 27.
7
Local Stem Cell Therapy for Crohn's Perianal Fistulae.
Inflamm Bowel Dis. 2019 Apr 11;25(5):816-819. doi: 10.1093/ibd/izy362.
8
Human orbital adipose tissue-derived mesenchymal stem cells possess neuroectodermal differentiation and repair ability.
Cell Tissue Res. 2019 Dec;378(3):531-542. doi: 10.1007/s00441-019-03072-0. Epub 2019 Aug 3.
9
Isolation and identification of mesenchymal stem cells from human lipoma tissue.
Biochem Biophys Res Commun. 2007 Oct 5;361(4):883-9. doi: 10.1016/j.bbrc.2007.07.116. Epub 2007 Jul 30.
10
[Application of adipose stem cells in tissue repair and reconstruction].
Zhonghua Shao Shang Za Zhi. 2019 Sep 20;35(9):641-644. doi: 10.3760/cma.j.issn.1009-2587.2019.09.001.
引用本文的文献
1
Detection of Residual iPSCs Following Differentiation of iPSC-Derived Retinal Pigment Epithelial Cells.
J Ocul Pharmacol Ther. 2024 Dec;40(10):680-687. doi: 10.1089/jop.2024.0130. Epub 2024 Oct 2.
2
No Tumorigenicity of Allogeneic Induced Pluripotent Stem Cells in Major Histocompatibility Complex-matched Cynomolgus Macaques.
Cell Transplant. 2021 Jan-Dec;30:963689721992066. doi: 10.1177/0963689721992066.
3
Extracellular Vesicles as a Potential Therapy for Neonatal Conditions: State of the Art and Challenges in Clinical Translation.
Pharmaceutics. 2019 Aug 11;11(8):404. doi: 10.3390/pharmaceutics11080404.
4
Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson's Disease.
Sci Rep. 2016 Sep 30;6:34478. doi: 10.1038/srep34478.
5
Insurance approval of mesenchymal stem cell for acute GVHD in Japan: need of follow up for some remaining concerns.
Int J Hematol. 2016 Feb;103(2):155-64. doi: 10.1007/s12185-015-1930-x. Epub 2016 Jan 12.
6
Microvesicles Derived From Human Mesenchymal Stem Cells Restore Alveolar Fluid Clearance in Human Lungs Rejected for Transplantation.
Am J Transplant. 2015 Sep;15(9):2404-12. doi: 10.1111/ajt.13271. Epub 2015 Apr 6.
7
Adult human mesenchymal stromal cells and the treatment of graft versus host disease.
Stem Cells Cloning. 2014 Feb 28;7:45-52. doi: 10.2147/SCCAA.S37506. eCollection 2014.
8
Tumorigenicity studies of induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) for the treatment of age-related macular degeneration.
PLoS One. 2014 Jan 14;9(1):e85336. doi: 10.1371/journal.pone.0085336. eCollection 2014.
9
Pre- and postnatal transplantation of fetal mesenchymal stem cells in osteogenesis imperfecta: a two-center experience.
Stem Cells Transl Med. 2014 Feb;3(2):255-64. doi: 10.5966/sctm.2013-0090. Epub 2013 Dec 16.
10
Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.
Ann Am Thorac Soc. 2013 Oct;10(5):S45-97. doi: 10.1513/AnnalsATS.201304-090AW.
本文引用的文献
1
Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells.
Exp Cell Res. 2010 May 15;316(9):1648-50. doi: 10.1016/j.yexcr.2010.02.016. Epub 2010 Feb 18.
2
A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.
J Am Coll Cardiol. 2009 Dec 8;54(24):2277-86. doi: 10.1016/j.jacc.2009.06.055.
3
Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation.
Cancer Res. 2009 Jul 1;69(13):5331-9. doi: 10.1158/0008-5472.CAN-08-4630. Epub 2009 Jun 9.
4
Persistent use of "false" cell lines.
Int J Cancer. 2008 Jan 1;122(1):1-4. doi: 10.1002/ijc.23233.
5
Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms.
Cancer Res. 2007 Oct 1;67(19):9142-9. doi: 10.1158/0008-5472.CAN-06-4690.
6
Sarcoma derived from cultured mesenchymal stem cells.
Stem Cells. 2007 Feb;25(2):371-9. doi: 10.1634/stemcells.2005-0620. Epub 2006 Oct 12.
7
Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture.
Cytotherapy. 2005;7(6):509-19. doi: 10.1080/14653240500363216.
8
Spontaneous human adult stem cell transformation.
Cancer Res. 2005 Apr 15;65(8):3035-9. doi: 10.1158/0008-5472.CAN-04-4194.
9
Multistage carcinogenesis in cell culture.
Dev Biol (Basel). 2001;106:61-6; discussion 67, 143-60.
10
Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes.
Nature. 2001 Feb 1;409(6820):633-7. doi: 10.1038/35054579.
Zotero 插件